Exoskeletons: types, applications and certification challenges

The exoskeletons have established themselves as one of the most innovative technologies in the field of applied biomechanics, with remarkable growth both in clinical rehabilitation and in industrial and healthcare environments. These devices, designed to assist or increase human motor capacity, combine mechanical engineering, electronic control and in-depth knowledge of human movement.

However, their increasing adoption poses a key challenge: how to technically and clinically validate these complex systems and how to certify them according to current European regulations. In this article we analyze the main types of exoskeletons, their most relevant applications and the challenges associated with their certification as medical devices.

Types of exoskeletons according to design and functionality

Exoskeletons can be classified according to different technical and functional criteria, which directly influences testing and certification requirements.

Passive exoskeletons

They do not incorporate actuators or active control systems. They use mechanical elements such as springs, shock absorbers or elastic structures to redistribute loads and reduce the user’s physical effort. They are common in occupational risk prevention and postural assistance.

Active exoskeletons

They integrate motors, sensors and control algorithms that actively assist movement. They are mainly used in neurological rehabilitation, spinal cord injury and gait support. Their technical complexity requires much more extensive validation.

Hybrid exoskeletons

They combine passive and active elements, seeking a balance between mechanical simplicity and motorized assistance. Their use is growing in outpatient clinical applications.

Main applications of exoskeletons

The versatility of these devices has allowed their adoption in multiple sectors.

Clinical rehabilitation

In hospitals and rehabilitation centers, exoskeletons are used for:

  • gait re-education after stroke,
  • rehabilitation of spinal cord injuries,
  • treatment of neuromuscular pathologies,
  • improvement of mobility in geriatric patients.

In these cases, they are usually classified as medical devices under MDR 2017/745, which implies strict safety and clinical evidence requirements.

The Lokomat case study shows how biomechanical gait analysis helps build that evidence.

Functional assistance and personal mobility

Exoskeletons designed to facilitate activities of daily living for people with reduced mobility. Although they are not always used in clinical settings, they may fall within the medical regulatory framework depending on their purpose.

Industry and occupational ergonomics

In occupational risk prevention, exoskeletons reduce musculoskeletal loading in repetitive or load handling tasks. Their certification usually follows different regulatory frameworks, although the biomechanical principles of validation are similar.

exoskeletons-certifications

Technical challenges in the validation of exoskeletons

Validation of an exoskeleton goes far beyond testing its structural strength.

Biomechanical complexity

The exoskeleton interacts directly with the human body. It is essential to evaluate:

  • load distribution in joints,
  • alignment with the anatomical axes,
  • adaptation to different anthropometries,
  • impact on the kinematics and dynamics of motion.

Control and safety systems

In active exoskeletons, the algorithms must respond safely to:

  • losses of equilibrium,
  • sensor failures,
  • power interruptions,
  • unexpected user movements.

Durability and reliability

These devices are subjected to thousands of cycles of use. Fatigue tests on structures, joints and actuators are critical to ensure their long-term reliability.

Regulatory and certification challenges

From a regulatory standpoint, exoskeletons present a particularly complex scenario.

Classification as a medical device

When the exoskeleton is intended for therapeutic purposes, the manufacturer must demonstrate compliance with MDR 2017/745, which implies:

  • risk management,
  • clinical evaluation,
  • post-marketing surveillance,
  • complete technical documentation.

Lack of specific harmonized standards

There is currently no single ISO standard specific to exoskeletons. Therefore, certification is based on:

  • general mechanical standards,
  • electrical safety standards,
  • customized biomechanical testing,
  • clinical evaluation guidelines.

This reinforces the need to work with laboratories specialized in applied biomechanics, capable of designing ad hoc test protocols.

IBV’s role in the validation of exoskeletons

The Biomechanics Institute of Valencia has advanced infrastructures for:

  • mechanical and fatigue tests,
  • analysis of human movement,
  • electromyography,
  • functional evaluation with real users,
  • technical support in regulatory processes.

This combination makes it possible to approach exoskeleton validation from a comprehensive perspective : technical, biomechanical and clinical, aligned with MDR requirements.

Frequently asked questions about exoskeletons and their certification

What types of exoskeletons are there? There are passive, active and hybrid exoskeletons. Passive ones redistribute loads through mechanical elements, while active ones include actuators and control systems to assist movement.
When is an exoskeleton considered a medical device? When its purpose is therapeutic or rehabilitative, the exoskeleton must be certified as a medical device under the MDR 2017/745.
Which technical tests are needed to validate an exoskeleton? They include structural strength and fatigue tests, stability, load distribution, ergonomics, functional safety and biomechanical analysis of movement.
Why is there no specific ISO standard for exoskeletons? Because it is an emerging and highly heterogeneous technology. General standards and custom protocols adapted to each device are currently used.
How does IBV support exoskeleton certification? IBV performs biomechanical and technical tests, evaluates human-device interaction and advises on generating the technical and clinical evidence needed to comply with the MDR.
Medical Device Testing in Europe: A Guide for International Manufacturers

Medical Device Testing in Europe: A Guide for International Manufacturers

For a medical device manufacturer based outside the European Union, selecting a testing laboratory in Europe can be a strategic decision. It is not merely a matter of completing a…

How to Measure the Outcomes of Robotic Rehabilitation Through Gait Analysis: The Lokomat Case Study

How to Measure the Outcomes of Robotic Rehabilitation Through Gait Analysis: The Lokomat Case Study

The incorporation of robots and exoskeletons into neurorehabilitation programs opens up new possibilities for intensifying gait training. However, for hospitals, developers, and manufacturers of healthcare technology, it is not enough…

QMSR, Quality Management System Regulation. What changes for a manufacturer that exports to multiple markets

QMSR, Quality Management System Regulation. What changes for a manufacturer that exports to multiple markets

For years, comparing ISO 13485 with the U.S. Quality System Regulation meant maintaining two parallel frameworks: the international standard and the detailed requirements of 21 CFR Part 820. As of…